Dr Emma Woodward

Dr Emma R. Woodward is a Clinical Geneticist specialising in hereditary cancer predisposition.
Dr Woodward studied medicine at the University of Cambridge where she also completed a PhD studying familial phaeochromocytoma and familial renal cancer. She then undertook training in adult medicine in London, Lausanne and N. Ireland prior to her higher specialist training in Clinical Genetics in Birmingham. During this time Dr Woodward received an NIHR Clinician Scientist Award and undertook further study of familial renal cancer. She became a consultant at Birmingham Women’s Hospital in 2008 and at Saint Mary’s Hospital in 2015.

Dr Woodward is an Alliance of Cancer Early Detection (ACED) Director of Research for Trials and Children’s Research Lead for the NIHR Manchester Biomedical Research Centre (BRC).

Dr Woodward’s current research is aimed at improving cancer prevention and early detection strategies for families with a hereditary cancer predisposition. She is Co-Lead of the ACED-funded study: DONATION (HereDitary homologous recOmbination repair deficiency: defining and modeling the evolutioNary ecosystem to identify novel candidates for cancer eArly deTection and InterceptiOn, the paNreatic ductal adenocarcinoma (PDAC) paradigm) and Principal Investigator of a Cancer Research UK-funded project to calculate risk of subsequent primary cancers in hereditary retinoblastoma and Li-Fraumeni syndrome.